A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects with Chronic Anovulation Using the Gonal-f Prefilled Pen in Women Undergoing Ovulation Induction
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- Acronyms LoGo
- Sponsors Merck KGaA; Merck Serono
- 30 Jun 2016 Status changed from completed to discontinued because of delays in sourcing replacement Investigational Medicinal Product for the study due to manufacturing delays
- 20 Nov 2014 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
- 29 Apr 2014 According to the ClinicalTrials.gov record, Status changed from recruiting to active, no longer recruiting.